Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

The American Journal of Psychiatry
Douglas L Leslie, Robert A Rosenheck

Abstract

The purpose of the study was to determine the proportion of patients with schizophrenia with a stable regimen of antipsychotic monotherapy who developed diabetes or were hospitalized for ketoacidosis. Patients with schizophrenia for whom a stable regimen of antipsychotic monotherapy was consistently prescribed during any 3-month period between June 1999 and September 2000 and who had no diabetes were followed through September 2001 by using administrative data from the Department of Veterans Affairs. Cox proportional hazards models were developed to identify the characteristics associated with newly diagnosed diabetes and ketoacidosis. Of the 56,849 patients identified, 4,132 (7.3%) developed diabetes and 88 (0.2%) were hospitalized for ketoacidosis. Diabetes risk was highest for clozapine (hazard ratio=1.57) and olanzapine (hazard ratio=1.15); the diabetes risks for quetiapine (hazard ratio=1.20) and risperidone (hazard ratio=1.01) were not significantly different from that for conventional antipsychotics. The attributable risks of diabetes mellitus associated with atypical antipsychotics were small, ranging from 0.05% (risperidone) to 2.03% (clozapine). Although clozapine and olanzapine have greater diabetes risk, the attribu...Continue Reading

Citations

Jul 3, 2007·Social Psychiatry and Psychiatric Epidemiology·Carolyn HarleyWilliam Carson
Jan 25, 2013·Psychopharmacology·Melanie D GuenetteGary J Remington
Nov 9, 2007·European Archives of Psychiatry and Clinical Neuroscience·Jaana SuvisaariAntti Reunanen
Jul 20, 2007·Schizophrenia Bulletin·R A RosenheckMichael Sernyak
Aug 20, 2005·Southern Medical Journal·Leslie CitromeCristina Damatarca
May 25, 2006·Current Opinion in Psychiatry·Corrado Barbui, Mauro Percudani
Oct 2, 2007·Southern Medical Journal·Leslie Citrome
Feb 2, 2006·Diabetes, Obesity & Metabolism·Richard I G Holt, Robert C Peveler
Jul 23, 2011·Implementation Science : IS·Christian D HelfrichAnne E Sales
Apr 1, 2007·Neuropsychiatric Disease and Treatment·Michael RiedelHans-Jürgen Möller
Dec 13, 2006·Drugs & Aging·Pietro GareriGiovambattista De Sarro
Jul 2, 2014·The Journal of Behavioral Health Services & Research·Angela M GerolamoJane Kogan
Jun 3, 2008·The British Journal of Psychiatry : the Journal of Mental Science·M SmithK Ismail
Oct 5, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Lars Vedel KessingPer Kragh Andersen
Apr 13, 2005·Clinical Therapeutics·John W Newcomer
Oct 1, 2005·International Review of Psychiatry·Jonathan MeyerGilbert J L'Italien
May 1, 2005·Expert Review of Clinical Immunology·Brian E Leonard
Sep 2, 2008·Expert Opinion on Drug Safety·Pietro GareriGiovambattista De Sarro
Nov 1, 2005·Expert Opinion on Drug Safety·Jambur AnanthSteven Brown
Oct 25, 2008·Current Medical Research and Opinion·Andrew DaviesMarc van Baardewijk
Apr 20, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·George LiamisMoses Elisaf
Mar 18, 2009·Journal of the American Pharmacists Association : JAPhA·L Douglas RiedJoel R McConkey
Aug 18, 2006·Journal of the American Pharmacists Association : JAPhA·L Douglas RiedLarry M Lopez
Dec 15, 2010·Thérapie·Leila ChebaneUNKNOWN Centres Régionaux de Pharmacovigilance Français
Jan 20, 2006·Pediatric Annals·Vikhyat S BebartaMichael G Gonzalez
Mar 17, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·F C J Starrenburg, J P A M Bogers
Feb 4, 2009·Journal of the American Medical Directors Association·Stewart G AlbertErin Green
May 5, 2007·American Journal of Preventive Medicine·Robert F AndaWayne H Giles
Feb 5, 2005·Human Psychopharmacology·M TaylorUNKNOWN Relapse Prevention in Schizophrenia Consensus Group
Jan 3, 2013·Journal of Forensic Sciences·Susan F ElyJames R Gill

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here